September 2023 - Page 4 of 7

TuesdaySep 19, 2023 9:45 am

RJD Green Inc. (RJDG) Subsidiary, Silex Holdings Undertakes Efficiency Drive, Implements StoneAPP within Operations

Silex Holdings, a subsidiary of holding company RJD Green, revealed that they would be implementing the use of software platform, StoneAPP across its business The software is expected to assist the company in both, reducing overall inventory costs whilst generating other ancillary savings expected to total as much as $300,000 per annum Silex has been a recent beneficiary of the U.S. home renovation boom, seeing its orderbook swell to record levels The company has simultaneously looked to introduce further operational efficiencies within its business, with StoneAPP’s implementation amongst these Silex Holdings Inc, a Tulsa, Oklahoma-based wholesaler and distributor of kitchen…

TuesdaySep 19, 2023 9:00 am

From Instagram to High Times: Unpacking the Power of Vast User Networks

NetworkNewsWire Editorial Coverage: In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company's core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized…

TuesdaySep 19, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Is ‘One to Watch’

SenesTech announced in August 2023 the closing of an exercise of warrants to purchase nearly 3 million shares of its common stock, with proceeds earmarked for existing product launches The company in July 2023 began delivery of the Isolate Bait System(TM), its newest delivery system for ContraPest(R) SenesTech reported Q2 2023 revenues of $305,000, compared to $277,000 in Q2 2022 The company reported gross profit of $142,000 in Q2 2023, compared to $136,000 for the same period one year earlier In May 2023, investment firm H.C. Wainwright & Co. had a ‘Buy’ rating on SenesTech shares SenesTech (NASDAQ: SNES) is…

MondaySep 18, 2023 10:30 am

420 Expo 2023: Celebrating the Cannabis Culture

Cannabis enthusiasts, investors, decision-makers, and business owners, are invited to attend the 420 Expo 2023 to be held in New Jersey Expo Center, Edison, NJ from September 29 – October 1, 2023. The electrifying event is set to blaze the ever-evolving cannabis landscape, including medical experts discussing the therapeutic potential of cannabis and professionals sharing their success stories. 420 Expo 2023 is a one-of-a-kind gathering that celebrates the world of cannabis culture, from its insightful medical applications to its important role in mainstream culture. Featuring the legendary Cheech Marin as a special guest host, the dynamic cannabis convergence promises to…

MondaySep 18, 2023 9:45 am

Near Intelligence Inc. (NASDAQ: NIR) Is ‘One to Watch’

For Q2 2023 ended June 30, Near reported revenue of $17.7 million, up 19% over Q2 2022 For the same 2023 period, the company reported GAAP gross profit of $12.1 million Near’s GAAP gross margin for Q2 2023 was 68% The company’s Q3 2023 guidance forecasts total revenue in the range of $18 million to $20 million Near holds 10 patents globally and has a multiyear head start on gathering unique data points Near Intelligence (NASDAQ: NIR), a Privacy-Safe Geospatial Intelligence Platform, curates one of the world’s largest sources of intelligence on people and places. Near’s patented technology analyzes data…

MondaySep 18, 2023 9:00 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Focused on Finding, Delivering Tellerium, the ‘Bright Future of Solar Energy’

USGS reports that tellurium’s primary use is for manufacturing films essential to photovoltaic solar cells Most tellurium is indirectly mined because it is a byproduct of milled copper, iron and other base-metal-rich ore bodies First Tellurium is exploring, developing tellurium projects, confident that demand for tellurium will increase Calling tellurium “the bright future of solar energy,” the U.S. Geological Survey (“USGS”) has prepared a report about the rare metal as part of its mission to conduct research and provide information about nonfuel mineral resources (https://nnw.fm/GGsTP). As a company committed to exploring and providing green and critical metals, First Tellurium (CSE:…

FridaySep 15, 2023 9:45 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announce New Mining Updates; Confirm Timeline for NI-43101 Compliant MRE Report Publication

Eloro Resources recently provided an update on the company’s ongoing exploratory drill work Recent findings revealed a number of holes with well-mineralized intersections, suggesting both – robust mineralization trends as well as an ever-widening prospective target area Global tin demand is set to grow by nearly a third over the next 8 years, however, the supply growth picture is looking increasingly tenuous Eloro Resources looks well positioned to capitalize from the ongoing growth in demand for the commodity, with the company having published its inaugural MRE report at the end of August Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM),…

FridaySep 15, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) is On Track for IND Application with the FDA for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria’s IND application for its U.S. Phase 1b Hypertension Clinical Study, HYPER-H23-1, remains on track despite setbacks Work mostly under Lexaria’s control was completed earlier this year, while work that is outside its control remains delayed Regardless, Lexaria continues to make progress, even as it looks to take advantage of the growing global cardiovascular drugs market, which is projected to post a CAGR of 3.1% between 2021 and 2026 Chris Bunka, Lexaria’s CEO, has lauded the company’s exceptional discovery, which demonstrates the ability of the patented DehydraTECH-processed CBD to lower blood pressure in the patient population Lexaria Bioscience (NASDAQ: LEXX),…

ThursdaySep 14, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company’s CEO, will discuss Longeveron’s cellular therapy programs in a pre-recorded presentation. Both he and Lisa Locklear, EVP & Chief Financial Officer, will be at the conference to discuss the company’s investment strategies and clinical trial progress The company aims to create awareness among scientists and investors of its clinical trial progress, positive clinical results, and cellular therapy programs Longeveron is evaluating its lead investigational product candidate, a cellular product named Lomecel-B(TM), in ongoing clinical trials…

ThursdaySep 14, 2023 9:00 am

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

U.S.-based generic drug developer SOHM recently announced the addition of two leading officers — Dr. David Aguilar (Ph.D) as Chief Operating Officer and Dr. Krishna Bhat (MD, Ph.D, FACC) as Chief Medical Advisor The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins SOHM also recently announced an LOI to acquire a stem cell disruptive technology and related patents, which include the potential for someday treating damaged hearts via…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: September 2023